Afraxis, Inc.
Biotechnology company · San Diego, California, United States
Afraxis, Inc. is a biotechnology company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2007. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $204,508 in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $45,000 sold in a notice filed in 2012.
Afraxis at a glance
What does Afraxis do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $204,508 in total (2017). NIH funding came from the National Institute on Aging.
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $45,000 sold (2012).
Frequently asked questions about Afraxis
Where is Afraxis headquartered?
Afraxis, Inc. is headquartered in San Diego, California, United States.
What does Afraxis do?
Afraxis, Inc. is a biotechnology company.
When was Afraxis founded?
The earliest incorporation on record for Afraxis, Inc. is in 2007, according to public company registers.
Similar companies
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- ImmunityBio, Inc.San Diego, California, United States
- Sorrento Therapeutics, Inc.San Diego, California, United States
- Protego Biopharma, Inc.San Diego, California, United States
- Tempo Therapeutics, Inc.San Diego, California, United States
- Fate Therapeutics IncSan Diego, California, United States
- ImageneBio, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences